DHR monthly performance report
Monthly DHR research: returns, drawdown, relative strength, seasonality, and key stats.
DHR monthly report
—
Key takeaways
- Danaher Corporation (DHR) closed September 2026 at $209.91, down 1.71% for the month and +3.00% over the trailing 12 months.
- Year-to-date, DHR is −8.30%, underperforming the S&P 500 which has returned +12.21% YTD.
- The stock is trading +3.22% versus its 200-day moving average ($203.36), a bullish technical signal.
- Over the past three years, DHR has underperformed the S&P 500 by −80.43%, with a relative strength index reading of 53.3.
- Win rate over the trailing 39 months stands at 48.7% — 19 positive months versus 20 negative months.
Danaher Corporation ended September 2026 at $209.91, posting a monthly return of −1.71%. The S&P 500 returned −0.25% over the same window, leaving relative performance at −1.46%.
The current quarter stands at +7.44% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +3.22% versus the 200-day moving average ($203.36).
Year-to-date, DHR is −8.30% against SPY +12.21%, a gap of −20.51%. The stock is currently −13.55% below its 52-week high, with maximum 3-year drawdown at −42.33%.
| Period | DHR | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +1.44% | +0.44% | +1.00% |
| 1 Week | −2.81% | −0.12% | −2.69% |
| 1 Month | −1.71% | −0.25% | −1.46% |
| 3 Months | +16.70% | +0.74% | +15.97% |
| 6 Months | −0.35% | +11.48% | −11.82% |
| YTD | −8.30% | +12.21% | −20.51% |
| 12 Months | +3.00% | +19.51% | −16.50% |
| 3 Years | −10.85% | +69.59% | −80.43% |
| Rank | Month | Return |
|---|---|---|
| #1 | Nov 2023 | +16.41% |
| #2 | Jul 2024 | +10.84% |
| #3 | Oct 2025 | +8.39% |
| #4 | Aug 2026 | +8.22% |
| #5 | Jul 2023 | +7.35% |
| Rank | Month | Return |
|---|---|---|
| #1 | Oct 2023 | −12.33% |
| #2 | Oct 2024 | −11.83% |
| #3 | Mar 2026 | −8.85% |
| #4 | Sep 2023 | −7.44% |
| #5 | Apr 2026 | −6.09% |
| Quarter | Return |
|---|---|
| Q2 2025 | −2.31% |
| Q3 2025 | +2.21% |
| Q4 2025 | +16.61% |
| Q1 2026 | −16.30% |
| Q2 2026 | −0.46% |
| Q3 2026 (QTD) | +7.44% |
| Year | Return |
|---|---|
| 2023 | −1.52% |
| 2024 | −1.28% |
| 2025 | +4.79% |
| 2026 | −10.48% |
| Metric | Value |
|---|---|
| 52-Week High | $242.80 (2026-01-22) |
| 52-Week Low | $160.93 (2026-05-15) |
| Current Price | $209.91 |
| 200-Day Moving Average | $203.36 |
| Price vs 200DMA | +3.22% |
| 3-Year Maximum Drawdown | −42.33% (2026-05-15) |
| Current Drawdown from 52W High | −13.55% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 53.3 |
| 3-Year Excess Return vs S&P 500 | −80.43% |
| RS Peak | 101.1 (Aug 2024) |
| RS Trough | 42.6 (May 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was DHR's return for this report period?
DHR returned −1.71% in the latest monthly window ending 2026-09-02.
Has DHR outperformed SPY year to date?
YTD DHR: −8.30% vs SPY: +12.21%.
What is DHR's 12-month return?
+3.00% over the trailing 12 months.
Is DHR above or below its 200-day moving average?
Price is +3.22% versus 200DMA ($203.36).
What is the maximum drawdown in the 3-year window?
−42.33% on 2026-05-15.